|
Potential for new dual therapy approaches in melanoma
|
|
A recent study suggests that genes such as ERBB2, KIT, FGFR3, and RET might be relevant in the treatment of individual patients with cutaneous melanoma. |
|
|
|
Targeted therapy for skin malignancies
|
|
The past decade has seen significant advances in the understanding of molecular pathogenesis of skin cancer. As a result, more targeted treatments and immunotherapies have been developed, leading to dramatically improved progression free survival and even overall survival. |
